Synonyms: Agamree® | VBP-15 | VBP15
vamorolone is an approved drug (FDA & EMA (2023))
Compound class:
Synthetic organic
Comment: Vamorolone (VBP15) is a novel, oral non-hormonal steroid modulator, that was investigated in Duchenne muscular dystrophy. It is a multi-functional drug that exhibits anti-inflammatory, membrane stabilisation, and mineralocorticoid receptor antagonist activities. Vamorolone was proposed as a potential replacement for the corticosteroids that are currently used in DMD, as it appears to cause fewer of the common corticosteroid adverse effects [4].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA & EMA (2023)) |
IUPAC Name |
(8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one |
International Nonproprietary Names | |
INN number | INN |
10419 | vamorolone |
Synonyms |
Agamree® | VBP-15 | VBP15 |
Database Links | |
BindingDB Ligand | 50432396 |
CAS Registry No. | 13209-41-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2348780 |
GtoPdb PubChem SID | 315661322 |
PubChem CID | 3035000 |
Search Google for chemical match using the InChIKey | ZYTXTXAMMDTYDQ-DGEXFFLYSA-N |
Search Google for chemicals with the same backbone | ZYTXTXAMMDTYDQ |
Search PubMed clinical trials | vamorolone |
Search PubMed titles | vamorolone |
Search PubMed titles/abstracts | vamorolone |
UniChem Compound Search for chemical match using the InChIKey | ZYTXTXAMMDTYDQ-DGEXFFLYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZYTXTXAMMDTYDQ-DGEXFFLYSA-N |